<?xml version='1.0'?>

<searchRetrieveResponse xmlns="http://www.loc.gov/zing/srw/">
<version>1.1</version>
<numberOfRecords>1</numberOfRecords>
<records>
<record><recordSchema>info:srw/schema/1/mods-v3.3</recordSchema><recordPacking>xml</recordPacking><recordData>
<mods version="3.3"
      xmlns:xlink="http://www.w3.org/1999/xlink"
      xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
      xmlns="http://www.loc.gov/mods/v3"
      xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd">
<genre>article</genre>

<titleInfo><title>High concentrations of phenylalanine stimulate peroxisome proliferator-activated receptor gamma: Implications for the pathophysiology of phenylketonuria</title></titleInfo>


<note type="publicationStatus">published</note>


<note type="qualityControlled">yes</note>

<name type="personal">
  <namePart type="given">Udo</namePart>
  <namePart type="family">Schumacher</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Zoltan</namePart>
  <namePart type="family">Lukacs</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Christian</namePart>
  <namePart type="family">Kaltschmidt</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="unibi">4430077</identifier></name>
<name type="personal">
  <namePart type="given">Christian</namePart>
  <namePart type="family">Freudlsperger</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Dorothea</namePart>
  <namePart type="family">Schulz</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Kai</namePart>
  <namePart type="family">Kompisch</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Reinhard</namePart>
  <namePart type="family">Mueller</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Tanja</namePart>
  <namePart type="family">Rudolph</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Rene</namePart>
  <namePart type="family">Santer</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Dietrich E.</namePart>
  <namePart type="family">Lorke</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Kurt</namePart>
  <namePart type="family">Ullrich</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>







<name type="corporate">
  <namePart>Institut für Genomforschung und Systembiologie</namePart>
  <identifier type="unibi">441929</identifier>
  <role>
    <roleTerm type="text">department</roleTerm>
  </role>
</name>

<name type="corporate">
  <namePart>Research Group  C. Kaltschmidt</namePart>
  <identifier type="unibi">33070578</identifier>
  <role>
    <roleTerm type="text">department</roleTerm>
  </role>
</name>

<name type="corporate">
  <namePart>Zellbiologie der Tiere</namePart>
  <identifier type="unibi">2685187</identifier>
  <role>
    <roleTerm type="text">department</roleTerm>
  </role>
</name>








<abstract lang="eng">If left untreated, the common inherited metabolic disorder phenylketonuria (PKU) presents with mental retardation and reduced brain weight. The underlying molecular reasons for these deficits are unknown so far. Using human neuroblastoma cells as a model for normal human neuroblasts elevated phenylalanine, concentrations suppressed proliferation of these cells in culture. Furthermore, microarray and functional assays of these cells revealed that both phenylalanine and the known PPAR gamma agonist rosiglitazone regulated the same set of genes causing subsequently similar changes in the functional assays. The lowered brain weight of PKU patients may thus be the result of reduced neuroblast proliferation caused by phenylalanine-induced stimulation of PPAR gamma receptors. The observation that high concentrations of small substrates can activate receptors may serve as a new paradigm for other metabolic diseases and provides a new approach for the treatment of these disorders by application of specific receptor antagonists. (C) 2008 Elsevier Inc. All rights reserved.</abstract>

<originInfo><publisher>ACADEMIC PRESS INC ELSEVIER SCIENCE</publisher><dateIssued encoding="w3cdtf">2008</dateIssued>
</originInfo>
<language><languageTerm authority="iso639-2b" type="code">eng</languageTerm>
</language>

<subject><topic>Peroxisome proliferator-activated receptor gamma</topic><topic>Pathophysiology</topic><topic>Neuroblastoma cells</topic><topic>Phenylketonuria</topic>
</subject>


<relatedItem type="host"><titleInfo><title>NEUROBIOLOGY OF DISEASE</title></titleInfo>
  <identifier type="issn">0969-9961</identifier>
  <identifier type="MEDLINE">18755275</identifier>
  <identifier type="ISI">000261602500007</identifier><identifier type="doi">10.1016/j.nbd.2008.07.020</identifier>
<part><detail type="volume"><number>32</number></detail><detail type="issue"><number>3</number></detail><extent unit="pages">385-390</extent>
</part>
</relatedItem>


<extension>
<bibliographicCitation>
<apa_indent>&lt;div style=&quot;text-indent:-25px; padding-left:25px;padding-bottom:0px;&quot;&gt;Schumacher, U., Lukacs, Z., Kaltschmidt, C., Freudlsperger, C., Schulz, D., Kompisch, K., Mueller, R., et al. (2008). High concentrations of phenylalanine stimulate peroxisome proliferator-activated receptor gamma: Implications for the pathophysiology of phenylketonuria. &lt;em&gt;NEUROBIOLOGY OF DISEASE&lt;/em&gt;, &lt;em&gt;32&lt;/em&gt;(3), 385-390.&lt;/div&gt;</apa_indent>
<mla>Schumacher, Udo, Lukacs, Zoltan, Kaltschmidt, Christian, Freudlsperger, Christian, Schulz, Dorothea, Kompisch, Kai, Mueller, Reinhard, Rudolph, Tanja, Santer, Rene, Lorke, Dietrich E., and Ullrich, Kurt. “High concentrations of phenylalanine stimulate peroxisome proliferator-activated receptor gamma: Implications for the pathophysiology of phenylketonuria”. &lt;em&gt;NEUROBIOLOGY OF DISEASE&lt;/em&gt; 32.3 (2008): 385-390.</mla>
<lncs>Schumacher, U., Lukacs, Z., Kaltschmidt, C., Freudlsperger, C., Schulz, D., Kompisch, K., Mueller, R., Rudolph, T., Santer, R., Lorke, D.E., Ullrich, K.: High concentrations of phenylalanine stimulate peroxisome proliferator-activated receptor gamma: Implications for the pathophysiology of phenylketonuria. NEUROBIOLOGY OF DISEASE. 32, 385-390 (2008).</lncs>
<ieee>U. Schumacher, et al., “High concentrations of phenylalanine stimulate peroxisome proliferator-activated receptor gamma: Implications for the pathophysiology of phenylketonuria”, &lt;em&gt;NEUROBIOLOGY OF DISEASE&lt;/em&gt;,  vol. 32, 2008,  pp. 385-390.</ieee>
<chicago>&lt;div style=&quot;text-indent:-25px; padding-left:25px;padding-bottom:0px;&quot;&gt;Schumacher, Udo, Lukacs, Zoltan, Kaltschmidt, Christian, Freudlsperger, Christian, Schulz, Dorothea, Kompisch, Kai, Mueller, Reinhard, et al. 2008. “High concentrations of phenylalanine stimulate peroxisome proliferator-activated receptor gamma: Implications for the pathophysiology of phenylketonuria”. &lt;em&gt;NEUROBIOLOGY OF DISEASE&lt;/em&gt; 32 (3): 385-390.&lt;/div&gt;</chicago>
<frontiers>Schumacher, U., Lukacs, Z., Kaltschmidt, C., Freudlsperger, C., Schulz, D., Kompisch, K., Mueller, R., Rudolph, T., Santer, R., Lorke, D. E., et al. (2008). High concentrations of phenylalanine stimulate peroxisome proliferator-activated receptor gamma: Implications for the pathophysiology of phenylketonuria. &lt;em&gt;NEUROBIOLOGY OF DISEASE&lt;/em&gt; 32, 385-390.</frontiers>
<apa>Schumacher, U., Lukacs, Z., Kaltschmidt, C., Freudlsperger, C., Schulz, D., Kompisch, K., Mueller, R., et al. (2008). High concentrations of phenylalanine stimulate peroxisome proliferator-activated receptor gamma: Implications for the pathophysiology of phenylketonuria. &lt;em&gt;NEUROBIOLOGY OF DISEASE&lt;/em&gt;, &lt;em&gt;32&lt;/em&gt;(3), 385-390.</apa>
<angewandte-chemie>U.  Schumacher, Z.  Lukacs, C.  Kaltschmidt, C.  Freudlsperger, D.  Schulz, K.  Kompisch, R.  Mueller, T.  Rudolph, R.  Santer, D. E.  Lorke, et al., “High concentrations of phenylalanine stimulate peroxisome proliferator-activated receptor gamma: Implications for the pathophysiology of phenylketonuria”, &lt;em&gt;NEUROBIOLOGY OF DISEASE&lt;/em&gt;, &lt;strong&gt;2008&lt;/strong&gt;, &lt;em&gt;32&lt;/em&gt;, 385-390.</angewandte-chemie>
<aps>U.  Schumacher, et al., High concentrations of phenylalanine stimulate peroxisome proliferator-activated receptor gamma: Implications for the pathophysiology of phenylketonuria, NEUROBIOLOGY OF DISEASE &lt;strong&gt;32&lt;/strong&gt;, 385-390 (2008).</aps>
<bio1>Schumacher U, Lukacs Z, Kaltschmidt C, Freudlsperger C, Schulz D, Kompisch K, Mueller R, Rudolph T, Santer R, Lorke DE, Ullrich K (2008) &lt;br /&gt;High concentrations of phenylalanine stimulate peroxisome proliferator-activated receptor gamma: Implications for the pathophysiology of phenylketonuria.&lt;br /&gt;NEUROBIOLOGY OF DISEASE 32(3): 385-390.</bio1>
<ama>Schumacher U, Lukacs Z, Kaltschmidt C, et al. High concentrations of phenylalanine stimulate peroxisome proliferator-activated receptor gamma: Implications for the pathophysiology of phenylketonuria. &lt;em&gt;NEUROBIOLOGY OF DISEASE&lt;/em&gt;. 2008;32(3):385-390.</ama>
<dgps>&lt;div style=&quot;text-indent:-25px; padding-left:25px;padding-bottom:0px;&quot;&gt;Schumacher, U., Lukacs, Z., Kaltschmidt, C., Freudlsperger, C., Schulz, D., Kompisch, K., Mueller, R., Rudolph, T., Santer, R., Lorke, D.E. &amp;amp; Ullrich, K. (2008). High concentrations of phenylalanine stimulate peroxisome proliferator-activated receptor gamma: Implications for the pathophysiology of phenylketonuria. &lt;em&gt;NEUROBIOLOGY OF DISEASE&lt;/em&gt;, &lt;em&gt;32&lt;/em&gt;(3), 385-390. ACADEMIC PRESS INC ELSEVIER SCIENCE. doi:10.1016/j.nbd.2008.07.020.&lt;/div&gt;</dgps>
<harvard1>Schumacher, U., et al., 2008. High concentrations of phenylalanine stimulate peroxisome proliferator-activated receptor gamma: Implications for the pathophysiology of phenylketonuria. &lt;em&gt;NEUROBIOLOGY OF DISEASE&lt;/em&gt;, 32(3), p 385-390.</harvard1>
<default>Schumacher U, Lukacs Z, Kaltschmidt C, Freudlsperger C, Schulz D, Kompisch K, Mueller R, Rudolph T, Santer R, Lorke DE, Ullrich K (2008) &lt;br /&gt;NEUROBIOLOGY OF DISEASE 32(3): 385-390.</default>
<wels>Schumacher, U.; Lukacs, Z.; Kaltschmidt, C.; Freudlsperger, C.; Schulz, D.; Kompisch, K.; Mueller, R.; Rudolph, T.; Santer, R.; Lorke, D. E.; Ullrich, K. (2008): High concentrations of phenylalanine stimulate peroxisome proliferator-activated receptor gamma: Implications for the pathophysiology of phenylketonuria &lt;em&gt;NEUROBIOLOGY OF DISEASE&lt;/em&gt;,32:(3): 385-390.</wels>
</bibliographicCitation>
</extension>
<recordInfo><recordIdentifier>1636528</recordIdentifier><recordCreationDate encoding="w3cdtf">2010-04-29T13:08:07Z</recordCreationDate><recordChangeDate encoding="w3cdtf">2011-09-22T08:17:09Z</recordChangeDate>
</recordInfo>
</mods>
</recordData><recordPosition>1</recordPosition></record>
</records>

<extraResponseData></extraResponseData> 
<echoedSearchRetrieveRequest><version>1.1</version><query>id=1636528</query><xQuery><searchClause xmlns="http://www.loc.gov/zing/cql/xcql/"><index>id</index><relation><value>=</value></relation><term>1636528</term></searchClause></xQuery></echoedSearchRetrieveRequest>
</searchRetrieveResponse>
